‘An unattractive deal with Iran is the best of limited bad options’ to get oil flowing again12 August 2026
Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy RideBy Press Room4 November 2024 Biosimilars offer clinically effective treatment alternatives to branded reference drugs at a lower cost. These products are making inroads in…